Effects of the TENS device, Exopulse Mollii Suit, on pain related to fibromyalgia: An open-label study

• Published in: Neurophysiologie clinique Vol. 53; no. 4; p. 102863
• Main Authors: Riachi, Naji, Chalah, Moussa A., Ahdab, Rechdi, Arshad, Feroza, Ayache, Samar S.
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01-08-2023
• Subjects: Fibromyalgia; Pain; Transcutaneous electrical nerve stimulation; Transcutaneous electrical nerve stimulation; Fibromyalgia; TENS; VAS; Pain; EEG
• DOI: 10.1016/j.neucli.2023.102863
• EISSN: 1769-7131
• ISSN: 0987-7053

Fibromyalgia is characterized by diffuse and chronic pain, that is often only partially alleviated by the available pharmacological treatments. Therefore, nonpharmacological interventions such as transcutaneous electrical stimulation (TENS) are highly needed to improve the quality of life of this population. However, the classical TENS devices offer a limited number of electrodes and are not adapted to this diffuse painful condition. For these reasons, we aimed to assess the effects of a new TENS device, the Exopulse Mollii Suit, that can stimulate up to 40 muscle groups integrated into pants and jackets and connected to a control unit. We report the data of 50 patients who received one session of active stimulation (pulse intensity 2 mA, and pulse frequency 20 Hz). Pain intensity was evaluated by means of the visual analogue scale (VAS), before (T0) and after the session (T1), and 24 h later (T24). Compared to baseline scores, a significant decrease in VAS was observed after the session (p<0.001), and 24 h later (p<0.001). T1 scores were significantly lower than T24 scores (p<0.001). Therefore, this new system seems to exert analgesic effects whose mechanisms primarily evoke the theory of "gate control". The effects were transient and started to decrease the following day, highlighting the need for additional studies to better evaluate the long-term effects of this intervention on pain, mood, and quality of life.